Placebo Clinical Trials

6 recruiting

Placebo Trials at a Glance

11 actively recruiting trials for placebo are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 2 with 5 trials, with the heaviest enrollment activity in Baltimore, Barcelona, and Birmingham. Lead sponsors running placebo studies include University of Maryland, Baltimore, Hospital General de Mexicali, and Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau.

Browse placebo trials by phase

Treatments under study

About Placebo Clinical Trials

Looking for clinical trials for Placebo? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Placebo trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Placebo clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

Oxytocin Plus Self-compassion Training in Borderline Personality Disorder

Self-compassion Training (SCT) Plus Intranasal OxytocinSelf-compassion Training (SCT) Plus Intranasal Placebo
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau80 enrolled1 locationNCT07551882
Recruiting
Early Phase 1

Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences

PlaceboNaltrexone
San Diego State University210 enrolled1 locationNCT05007561
Recruiting
Not Applicable

Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)

Temporomandibular DisorderPainVirtual Reality+1 more
University of Maryland, Baltimore78 enrolled2 locationsNCT06214923
Recruiting
Not Applicable

Effects of 8 Weeks of Turmeric Ingestion on Physiology and Wellbeing in Healthy Older Adults

PlaceboTurmeric
Nottingham Trent University80 enrolled1 locationNCT07196514
Recruiting
Not Applicable

The Effects of Exogenous Ketones on Cognitive Function

Placebo - ControlKetone Monoester
University of Alabama at Birmingham45 enrolled1 locationNCT07051655
Recruiting
Phase 2

Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper Endoscopy

EsophagogastroduodenoscopySimethiconeN-Acetylcysteine+7 more
Hospital General de Mexicali132 enrolled2 locationsNCT07245095
Recruiting
Phase 4

SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients

Randomized Controlled TrialKidney Transplantation RecipientsSodium-Glucose Transporter 2 Inhibitors+2 more
Odense University Hospital88 enrolled1 locationNCT07143773
Recruiting
Phase 2

Suvorexant as an Adjunct to Buprenorphine in Persons Who Use Fentanyl

PlaceboSuvorexant
Johns Hopkins University120 enrolled1 locationNCT05145764
Recruiting
Phase 2

Neural Correlates of Hypoalgesia Driven by Observation

PainVirtual RealityPlacebo
University of Maryland, Baltimore182 enrolled1 locationNCT03897998
Recruiting
Phase 1Phase 2

Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Acid and Brain-derived Neurotrophic Factor Levels

Depression - Major Depressive DisorderTranscranial Magnetic StimulationPlacebo
Universidad de Guanajuato40 enrolled1 locationNCT06667180
Recruiting
Not Applicable

"How Awareness and Subjectivity Modulate the Placebo Effect"

3 Placebo Groups in a Cycle Ergometer Session With Healthy Participants
Fondazione Don Carlo Gnocchi Onlus84 enrolled1 locationNCT06533137